Jackson RA - Search Results

1

Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes.

Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS. Bleich D, et al. Among authors: jackson ra. Diabetes Care. 1990 Feb;13(2):111-8. doi: 10.2337/diacare.13.2.111. Diabetes Care. 1990. PMID: 2190768

2

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G; Diabetes Prevention Trial-Type 1 Study Group. Orban T, et al. Diabetes Care. 2009 Dec;32(12):2269-74. doi: 10.2337/dc09-0934. Epub 2009 Sep 9. Diabetes Care. 2009. PMID: 19741189 Free PMC article.

3

Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators. Yu L, et al. Diabetes. 2001 Aug;50(8):1735-40. doi: 10.2337/diabetes.50.8.1735. Diabetes. 2001. PMID: 11473032

4

Standardization of IVGTT to predict IDDM.

Bingley PJ, Colman P, Eisenbarth GS, Jackson RA, McCulloch DK, Riley WJ, Gale EA. Bingley PJ, et al. Among authors: jackson ra. Diabetes Care. 1992 Oct;15(10):1313-6. doi: 10.2337/diacare.15.10.1313. Diabetes Care. 1992. PMID: 1425095

5

Insulin autoimmunity: the rate limiting factor in pre-type I diabetes.

Eisenbarth GS, Jackson RA, Pugliese A. Eisenbarth GS, et al. Among authors: jackson ra. J Autoimmun. 1992 Apr;5 Suppl A:241-6. doi: 10.1016/0896-8411(92)90039-s. J Autoimmun. 1992. PMID: 1503616 Review.

6

Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.

Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS. Gianani R, et al. Among authors: jackson ra. Diabetes. 1992 Mar;41(3):347-53. doi: 10.2337/diab.41.3.347. Diabetes. 1992. PMID: 1551494

7

Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.

Ziegler R, Alper CA, Awdeh ZL, Castano L, Brink SJ, Soeldner JS, Jackson RA, Eisenbarth GS. Ziegler R, et al. Among authors: jackson ra. Diabetes. 1991 Jun;40(6):709-14. doi: 10.2337/diab.40.6.709. Diabetes. 1991. PMID: 2040387

8

Predicting type I diabetes.

Ziegler AG, Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS. Ziegler AG, et al. Among authors: jackson ra. Diabetes Care. 1990 Jul;13(7):762-5. doi: 10.2337/diacare.13.7.762. Diabetes Care. 1990. PMID: 2201499 Review.

9

Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.

Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS. Herskowitz RD, et al. Among authors: jackson ra. J Autoimmun. 1989 Oct;2(5):733-7. doi: 10.1016/s0896-8411(89)80011-3. J Autoimmun. 1989. PMID: 2529865 No abstract available.

10

Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.

Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS. Ziegler AG, et al. Among authors: jackson ra. Diabetes. 1989 Oct;38(10):1320-5. doi: 10.2337/diab.38.10.1320. Diabetes. 1989. PMID: 2676660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters